| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | Mon1-Ccz1 complex | 4.31e-05 | 5 | 44 | 2 | GO:0035658 | |
| GeneOntologyCellularComponent | somatodendritic compartment | CNTNAP3 DYRK1A CACNA1D CNTNAP3B CNKSR2 SNPH SLC9A5 FARP1 AGER SCN8A | 1.87e-04 | 1228 | 44 | 10 | GO:0036477 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 5.77e-04 | 17 | 44 | 2 | GO:0001518 | |
| GeneOntologyCellularComponent | extrinsic component of postsynaptic membrane | 9.74e-04 | 22 | 44 | 2 | GO:0098890 | |
| GeneOntologyCellularComponent | guanyl-nucleotide exchange factor complex | 1.16e-03 | 24 | 44 | 2 | GO:0032045 | |
| GeneOntologyCellularComponent | synaptic membrane | 1.31e-03 | 583 | 44 | 6 | GO:0097060 | |
| GeneOntologyCellularComponent | neuronal cell body | 1.67e-03 | 835 | 44 | 7 | GO:0043025 | |
| GeneOntologyCellularComponent | sodium channel complex | 1.70e-03 | 29 | 44 | 2 | GO:0034706 | |
| MousePheno | anophthalmia | 4.57e-06 | 246 | 39 | 7 | MP:0001293 | |
| Domain | TF_fork_head_CS_2 | 4.46e-06 | 46 | 45 | 4 | IPR030456 | |
| Domain | TF_fork_head_CS_1 | 4.86e-06 | 47 | 45 | 4 | IPR018122 | |
| Domain | DUF1712 | 5.68e-06 | 2 | 45 | 2 | PF08217 | |
| Domain | DUF1712_fun | 5.68e-06 | 2 | 45 | 2 | IPR013176 | |
| Domain | FORK_HEAD_3 | 5.75e-06 | 49 | 45 | 4 | PS50039 | |
| Domain | FH | 5.75e-06 | 49 | 45 | 4 | SM00339 | |
| Domain | FORK_HEAD_1 | 5.75e-06 | 49 | 45 | 4 | PS00657 | |
| Domain | FORK_HEAD_2 | 5.75e-06 | 49 | 45 | 4 | PS00658 | |
| Domain | Forkhead | 5.75e-06 | 49 | 45 | 4 | PF00250 | |
| Domain | Fork_head_dom | 5.75e-06 | 49 | 45 | 4 | IPR001766 | |
| Domain | LAM_G_DOMAIN | 1.04e-04 | 38 | 45 | 3 | PS50025 | |
| Domain | Laminin_G_2 | 1.21e-04 | 40 | 45 | 3 | PF02210 | |
| Domain | LamG | 1.62e-04 | 44 | 45 | 3 | SM00282 | |
| Domain | VDCCAlpha1 | 2.52e-04 | 10 | 45 | 2 | IPR002077 | |
| Domain | Channel_four-helix_dom | 3.49e-04 | 57 | 45 | 3 | IPR027359 | |
| Domain | - | 3.49e-04 | 57 | 45 | 3 | 1.20.120.350 | |
| Domain | Laminin_G | 3.68e-04 | 58 | 45 | 3 | IPR001791 | |
| Domain | FA58C | 1.16e-03 | 21 | 45 | 2 | SM00231 | |
| Domain | FA58C_3 | 1.16e-03 | 21 | 45 | 2 | PS50022 | |
| Domain | FA58C_1 | 1.16e-03 | 21 | 45 | 2 | PS01285 | |
| Domain | FA58C_2 | 1.16e-03 | 21 | 45 | 2 | PS01286 | |
| Domain | F5_F8_type_C | 1.51e-03 | 24 | 45 | 2 | PF00754 | |
| Domain | FA58C | 1.51e-03 | 24 | 45 | 2 | IPR000421 | |
| Domain | - | 1.85e-03 | 218 | 45 | 4 | 1.10.10.10 | |
| Domain | Ion_trans_dom | 2.61e-03 | 114 | 45 | 3 | IPR005821 | |
| Domain | Ion_trans | 2.61e-03 | 114 | 45 | 3 | PF00520 | |
| Domain | Fibrinogen_a/b/g_C_dom | 2.69e-03 | 32 | 45 | 2 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 2.69e-03 | 32 | 45 | 2 | PS51406 | |
| Domain | FIBRINOGEN_C_1 | 2.69e-03 | 32 | 45 | 2 | PS00514 | |
| Domain | WHTH_DNA-bd_dom | 2.70e-03 | 242 | 45 | 4 | IPR011991 | |
| Pubmed | Neural transcription factors bias cleavage stage blastomeres to give rise to neural ectoderm. | 4.01e-11 | 6 | 46 | 4 | 27092474 | |
| Pubmed | The mouse fkh-2 gene. Implications for notochord, foregut, and midbrain regionalization. | 1.87e-10 | 8 | 46 | 4 | 8530406 | |
| Pubmed | An amphioxus winged helix/forkhead gene, AmphiFoxD: insights into vertebrate neural crest evolution. | 3.36e-10 | 9 | 46 | 4 | 12412011 | |
| Pubmed | A genetic study of the suppressors of the Engrailed-1 cerebellar phenotype. | 1.90e-09 | 13 | 46 | 4 | 16884697 | |
| Pubmed | 1.90e-09 | 13 | 46 | 4 | 7957066 | ||
| Pubmed | Six members of the mouse forkhead gene family are developmentally regulated. | 3.62e-09 | 15 | 46 | 4 | 7689224 | |
| Pubmed | 3.62e-09 | 15 | 46 | 4 | 22045912 | ||
| Pubmed | Expression of the winged helix genes fkh-4 and fkh-5 defines domains in the central nervous system. | 4.82e-09 | 16 | 46 | 4 | 8861101 | |
| Pubmed | 4.82e-09 | 16 | 46 | 4 | 10208738 | ||
| Pubmed | Functional equivalency between Otx2 and Otx1 in development of the rostral head. | 1.02e-08 | 19 | 46 | 4 | 9895322 | |
| Pubmed | 1.28e-08 | 20 | 46 | 4 | 12812790 | ||
| Pubmed | 1.58e-08 | 21 | 46 | 4 | 9449667 | ||
| Pubmed | 1.92e-08 | 22 | 46 | 4 | 17389379 | ||
| Pubmed | 2.16e-08 | 5 | 46 | 3 | 12234674 | ||
| Pubmed | Otx2 is required to respond to signals from anterior neural ridge for forebrain specification. | 2.79e-08 | 24 | 46 | 4 | 11820816 | |
| Pubmed | 2.79e-08 | 24 | 46 | 4 | 29992973 | ||
| Pubmed | Ssdp1 regulates head morphogenesis of mouse embryos by activating the Lim1-Ldb1 complex. | 3.92e-08 | 26 | 46 | 4 | 15857913 | |
| Pubmed | 6.21e-08 | 29 | 46 | 4 | 22972626 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 31150793 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 26807827 | ||
| Pubmed | Genome-scale study of transcription factor expression in the branching mouse lung. | 1.93e-06 | 67 | 46 | 4 | 22711520 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 32160108 | ||
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 20305638 | ||
| Pubmed | 1.71e-05 | 5 | 46 | 2 | 20353610 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 2.42e-05 | 440 | 46 | 6 | 34244565 | |
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 20630999 | ||
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 23991045 | ||
| Pubmed | In trans neuregulin3-Caspr3 interaction controls DA axonal bassoon cluster development. | 2.56e-05 | 6 | 46 | 2 | 34143959 | |
| Pubmed | 4.77e-05 | 8 | 46 | 2 | 28330839 | ||
| Pubmed | 9.34e-05 | 11 | 46 | 2 | 12421752 | ||
| Pubmed | Nucleoplasmic calcium regulates cell proliferation through legumain. | 9.34e-05 | 11 | 46 | 2 | 21237226 | |
| Pubmed | 1.12e-04 | 12 | 46 | 2 | 36402907 | ||
| Pubmed | 2.03e-04 | 16 | 46 | 2 | 24744753 | ||
| Pubmed | 2.30e-04 | 17 | 46 | 2 | 26389685 | ||
| Pubmed | Expression of murine cyclin B1 mRNAs and genetic mapping of related genomic sequences. | 2.58e-04 | 18 | 46 | 2 | 1387105 | |
| Pubmed | 3.29e-04 | 709 | 46 | 6 | 22988430 | ||
| Pubmed | FoxP1 orchestration of ASD-relevant signaling pathways in the striatum. | 3.89e-04 | 22 | 46 | 2 | 26494785 | |
| Pubmed | Diverse fates of paralogs following segmental duplication of telomeric genes. | 3.89e-04 | 22 | 46 | 2 | 15233989 | |
| Pubmed | 4.06e-04 | 263 | 46 | 4 | 20932939 | ||
| Pubmed | 4.64e-04 | 24 | 46 | 2 | 23728617 | ||
| Pubmed | Zfhx3 is required for the differentiation of late born D1-type medium spiny neurons. | 6.79e-04 | 29 | 46 | 2 | 31491374 | |
| Pubmed | 7.17e-04 | 306 | 46 | 4 | 18973680 | ||
| Pubmed | The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function. | 8.80e-04 | 33 | 46 | 2 | 22357600 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 1.17e-03 | 38 | 46 | 2 | 30786075 | |
| Pubmed | 1.29e-03 | 359 | 46 | 4 | 35559673 | ||
| Cytoband | 9q21.11 | 2.37e-08 | 30 | 46 | 4 | 9q21.11 | |
| Cytoband | 7p22.1 | 1.03e-03 | 47 | 46 | 2 | 7p22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q21 | 1.06e-03 | 199 | 46 | 3 | chr9q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9p11 | 1.26e-03 | 52 | 46 | 2 | chr9p11 | |
| GeneFamily | Calcium voltage-gated channel subunits | 5.38e-04 | 26 | 24 | 2 | 253 | |
| ToppCell | AT1_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 6.92e-07 | 162 | 46 | 5 | ae2ba4f21f6f6c512006fa531d670b88be7c04c9 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-06 | 181 | 46 | 5 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.37e-06 | 186 | 46 | 5 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-06 | 187 | 46 | 5 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.40e-06 | 187 | 46 | 5 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.81e-06 | 197 | 46 | 5 | 61c1c29a62d4c033999b7f0183c1e9cdd6a62925 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.90e-06 | 199 | 46 | 5 | 1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b | |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_1-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.90e-06 | 199 | 46 | 5 | c1daa481f88d5281b6b5ea8ec8bb70cc0907d613 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.95e-06 | 200 | 46 | 5 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.95e-06 | 200 | 46 | 5 | 9a6ae40f3e17cd44ee5fd73260713b920aa2ea15 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.90e-05 | 171 | 46 | 4 | 4ccd88cf812dd8bfdc55159c6f504e9c84e4f4fc | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.11e-05 | 174 | 46 | 4 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 3.11e-05 | 174 | 46 | 4 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.18e-05 | 175 | 46 | 4 | 711ace94fa9a763c6ae48171a690953f25deebe4 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-SMG_basal_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.18e-05 | 175 | 46 | 4 | 4462000b22af227555413ba202a872868eecde6c | |
| ToppCell | AT1_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 3.25e-05 | 176 | 46 | 4 | 4a30bb771297b30926fb98e2b5ec0dbdc46feac7 | |
| ToppCell | AT1_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 3.25e-05 | 176 | 46 | 4 | 458720776b0151cd55acc352d509599cb62f0ca8 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.32e-05 | 177 | 46 | 4 | ac8f774596068e66c0a9ea8a318be0ce5f5df834 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-aDC_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.32e-05 | 177 | 46 | 4 | ccf5dc54780d6039a4d062dee88440c011ddc0a3 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.32e-05 | 177 | 46 | 4 | d9c4a93b0e04a13bf39992dd1c1ec8df2c5f89fe | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.39e-05 | 178 | 46 | 4 | c227da59dc7beb73f84405bf13356bdeb59d9338 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.47e-05 | 179 | 46 | 4 | d5e3e7f1cd8f683f39a7416f12af7e766dcbead8 | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.47e-05 | 179 | 46 | 4 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 3.47e-05 | 179 | 46 | 4 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.47e-05 | 179 | 46 | 4 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.47e-05 | 179 | 46 | 4 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | severe-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.55e-05 | 180 | 46 | 4 | ac03812b1409435c55d323a7516deeac82bd3509 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-05 | 181 | 46 | 4 | 9542c19edc9bd2cba68c01c2a8407705398e3011 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-05 | 181 | 46 | 4 | 8f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5 | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 3.78e-05 | 183 | 46 | 4 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.78e-05 | 183 | 46 | 4 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 3.78e-05 | 183 | 46 | 4 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.86e-05 | 184 | 46 | 4 | cdf6f1c6cce97a7effa0c55959652e2c0b6992b3 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.86e-05 | 184 | 46 | 4 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.86e-05 | 184 | 46 | 4 | c7073d1b2c4fdb154d87678b92a0629c02116972 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.86e-05 | 184 | 46 | 4 | bde4eaabd3e9bdaed23867d23a919b9d84b52d4b | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.86e-05 | 184 | 46 | 4 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 3.86e-05 | 184 | 46 | 4 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.86e-05 | 184 | 46 | 4 | a809b0fa52df8a159f60f87eefcef61220af5e34 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.86e-05 | 184 | 46 | 4 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.86e-05 | 184 | 46 | 4 | cb15d6bae52c5ec251c2235859dc7e65f630ae23 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.86e-05 | 184 | 46 | 4 | 1ed558a88215b248431c524ea16f13d9022ae98c | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.95e-05 | 185 | 46 | 4 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.95e-05 | 185 | 46 | 4 | 3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.95e-05 | 185 | 46 | 4 | e87e6e097dc29ece8aea671935bde281b99b93ea | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.95e-05 | 185 | 46 | 4 | c82eab551f65ecebe6db908eda9f9eb3414693c7 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 4.03e-05 | 186 | 46 | 4 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.03e-05 | 186 | 46 | 4 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-05 | 186 | 46 | 4 | d6c8ce2a32c218dcc63d861cc247152430ed3c8c | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.11e-05 | 187 | 46 | 4 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells-Tumor_ECs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 4.11e-05 | 187 | 46 | 4 | 2713f526f86911fbbf6c7a3e69230f2e6bde31c3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.11e-05 | 187 | 46 | 4 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-05 | 187 | 46 | 4 | 7b2cd0c618ed081223343f3bec2244c8723c9a31 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 4.11e-05 | 187 | 46 | 4 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | HSPCs-Ery/Mk_prog.|World / Lineage and Cell class | 4.20e-05 | 188 | 46 | 4 | 5390089213cd6ee90dcdfd3c3f5b6765376cccf2 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.20e-05 | 188 | 46 | 4 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.20e-05 | 188 | 46 | 4 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.29e-05 | 189 | 46 | 4 | 6463890d8dbee4bc198f91628a5f784970de786a | |
| ToppCell | COVID-19-lung-Lymphatic_EC|lung / Disease (COVID-19 only), tissue and cell type | 4.29e-05 | 189 | 46 | 4 | c8db9aaf54ea3cc96c4a2f777c3389e0f31f67f3 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 4.29e-05 | 189 | 46 | 4 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | droplet-Limb_Muscle|droplet / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-05 | 190 | 46 | 4 | 06c2b13fa88abbcb8086f13b8d98a156e41e4198 | |
| ToppCell | COVID-19-lung-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.56e-05 | 192 | 46 | 4 | cbe57cda44232b183821ac633b60a2668265e616 | |
| ToppCell | 18-Airway-Epithelial-Bud_tip_adjacent|Airway / Age, Tissue, Lineage and Cell class | 4.75e-05 | 194 | 46 | 4 | b45f1e80074a19245bc5dc4b3a583419a1904404 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.84e-05 | 195 | 46 | 4 | 68f4cc84b5ae7f4159b780c78e4b66c94211779a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.84e-05 | 195 | 46 | 4 | 2a1863f4b9fe73c30b0b1acf9b12fc98ef65040f | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.84e-05 | 195 | 46 | 4 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-basal_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-05 | 195 | 46 | 4 | eaadc79f53b1cb208c6f7999925f318e1378197f | |
| ToppCell | mild_COVID-19|World / disease group, cell group and cell class (v2) | 4.84e-05 | 195 | 46 | 4 | 6dbe9db5f0e94f2e91b3d1282855d200051ab0ba | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.94e-05 | 196 | 46 | 4 | eb68f7954e7c2f86d05e740e95b6e74805a6053f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.94e-05 | 196 | 46 | 4 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | AT1|World / shred by cell class for parenchyma | 4.94e-05 | 196 | 46 | 4 | 2bc487f8a109a6961ebff111dec79c2227ea60ac | |
| ToppCell | (7)_Epithelial-I_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.94e-05 | 196 | 46 | 4 | 150554fa06868d29b0608189862eef6505ba757f | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.94e-05 | 196 | 46 | 4 | 6856317cd0cdcb88fe54b4ae905d91e13495b1c4 | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.94e-05 | 196 | 46 | 4 | 6731fef8c148b6681d6ed38afdf23c8213e0bbbe | |
| ToppCell | Severe-B_naive-2|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.94e-05 | 196 | 46 | 4 | 19687c52c0e8e00c9fb3df2898ac32bec1dc30ee | |
| ToppCell | wk_20-22-Epithelial-Distal_epithelial-type_I_pneumocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.94e-05 | 196 | 46 | 4 | e24a7aaf41793abba66c1189d933ca05b14c1af9 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-05 | 196 | 46 | 4 | d4df86ce289835e76763213641989fde77935a16 | |
| ToppCell | Epithelial_cells-AT1_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 4.94e-05 | 196 | 46 | 4 | 6c99d29162848161c1f166a032320f87a5d5a631 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.04e-05 | 197 | 46 | 4 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | Bronchial_Biopsy-Epithelial-Basal_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.04e-05 | 197 | 46 | 4 | a4855c5aebea4f0fed4eb035844572e82e5bac46 | |
| ToppCell | ASK440-Epithelial-Type_1|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.04e-05 | 197 | 46 | 4 | 1eda2c2504451a3d626dda5c2b2b12eeaa6bca54 | |
| ToppCell | ASK440-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.04e-05 | 197 | 46 | 4 | 782449c522c9e16e72bf999a73090688a3aefe06 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.04e-05 | 197 | 46 | 4 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | Mild/Remission-B_naive-2|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.04e-05 | 197 | 46 | 4 | 0042716ba630e4d5142cca46fcb279a2e64370f2 | |
| ToppCell | ASK452-Epithelial-Type_1|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.04e-05 | 197 | 46 | 4 | dc0a6dca4af6b216357b06f67203274f8b2a8bb0 | |
| ToppCell | AT1_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 5.04e-05 | 197 | 46 | 4 | 80d81be244c94c435accb643449b4ce6a3462c7f | |
| ToppCell | Biopsy_IPF-Epithelial-AT1|Biopsy_IPF / Sample group, Lineage and Cell type | 5.14e-05 | 198 | 46 | 4 | 75bdecbe111fededf6082b11de18b84ca308ef6d | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.14e-05 | 198 | 46 | 4 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.14e-05 | 198 | 46 | 4 | 50852713c017217c79777c95857097103bcf2fbe | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.14e-05 | 198 | 46 | 4 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-2_Progenitor|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.14e-05 | 198 | 46 | 4 | f006d68e6c51923be7772eea118546a5762e8a5e | |
| ToppCell | AT1-AT2_cells|World / lung cells shred on cell class, cell subclass, sample id | 5.14e-05 | 198 | 46 | 4 | a5b3617ea2ed4bffba59edcf6284799c2b3bbb29 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 5.14e-05 | 198 | 46 | 4 | 9f972f217d2c39d4c0f7d0d4227d0fffe8535b9d | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.14e-05 | 198 | 46 | 4 | c477405b093f4e5374e57bcacf1fb204a0f7eb3b | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.14e-05 | 198 | 46 | 4 | b3a020522e064bb61949d38e442f24026e339364 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1|Control_saline / Treatment groups by lineage, cell group, cell type | 5.14e-05 | 198 | 46 | 4 | 9b161285df7a4e51618f3517cfc5b8221ba55786 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 5.14e-05 | 198 | 46 | 4 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-stalk_late|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.14e-05 | 198 | 46 | 4 | 1851b7f4198b42c21c934e2fbda39dbd65e2625c | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.14e-05 | 198 | 46 | 4 | fc4b7c3ad52bc5c8b40fa04a156bfbb58afa2872 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.14e-05 | 198 | 46 | 4 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 5.25e-05 | 8 | 41 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | Hermansky-Pudlak syndrome (implicated_via_orthology) | 1.70e-04 | 14 | 41 | 2 | DOID:3753 (implicated_via_orthology) | |
| Disease | unipolar depression, mood disorder, response to antidepressant | 1.70e-04 | 14 | 41 | 2 | EFO_0003761, EFO_0004247, GO_0036276 | |
| Disease | serum alanine aminotransferase measurement | 1.76e-04 | 869 | 41 | 7 | EFO_0004735 | |
| Disease | liver volume | 1.96e-04 | 15 | 41 | 2 | EFO_0600048 | |
| Disease | proliferative diabetic retinopathy (is_marker_for) | 2.23e-04 | 16 | 41 | 2 | DOID:13207 (is_marker_for) | |
| Disease | renal fibrosis (implicated_via_orthology) | 2.53e-04 | 17 | 41 | 2 | DOID:0050855 (implicated_via_orthology) | |
| Disease | visuospatial function measurement | 5.99e-04 | 26 | 41 | 2 | EFO_0803533 | |
| Disease | joint hypermobility measurement | 9.68e-04 | 33 | 41 | 2 | EFO_0007905 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 1.19e-03 | 335 | 41 | 4 | EFO_0009931 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.24e-03 | 152 | 41 | 3 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Drug-induced agranulocytosis, response to clozapine | 1.57e-03 | 42 | 41 | 2 | GO_0097338, HP_0012235 | |
| Disease | ovarian serous carcinoma | 1.88e-03 | 46 | 41 | 2 | EFO_1001516 | |
| Disease | congenital left-sided heart lesions | 2.04e-03 | 48 | 41 | 2 | EFO_0005938 | |
| Disease | pulmonary fibrosis (biomarker_via_orthology) | 2.21e-03 | 50 | 41 | 2 | DOID:3770 (biomarker_via_orthology) | |
| Disease | diabetic retinopathy (is_implicated_in) | 2.21e-03 | 50 | 41 | 2 | DOID:8947 (is_implicated_in) | |
| Disease | nervous system disorder | 2.48e-03 | 53 | 41 | 2 | C0027765 | |
| Disease | non-alcoholic fatty liver disease, cirrhosis of liver | 2.48e-03 | 53 | 41 | 2 | EFO_0001422, EFO_0003095 | |
| Disease | systemic scleroderma (is_marker_for) | 2.48e-03 | 53 | 41 | 2 | DOID:418 (is_marker_for) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.52e-03 | 195 | 41 | 3 | DOID:1574 (implicated_via_orthology) | |
| Disease | diabetic retinopathy (is_marker_for) | 2.58e-03 | 54 | 41 | 2 | DOID:8947 (is_marker_for) | |
| Disease | IGFBP-3 measurement | 2.58e-03 | 54 | 41 | 2 | EFO_0004626 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TLYSFFSPSPARKRH | 6 | P13051 | |
| PTPGRSRAFRRKSFH | 316 | Q9BZ76 | |
| RSDPKSHGSYRFLAP | 111 | Q02928 | |
| KPSSVRLAPSFSFHA | 11 | Q13627 | |
| FSCSFSPGLPRHRAL | 206 | Q15109 | |
| SSKFPFGISPAQSHR | 1936 | O14497 | |
| TRGFTAPSKHFRSSK | 271 | P23352 | |
| GNSPSSLKFPSSHRR | 76 | P57682 | |
| SLKFPSSHRRASPGL | 81 | P57682 | |
| ARSAPKPSQASGHFS | 111 | Q9H6Y5 | |
| GRPGAKNFTFSHTLR | 236 | Q16787 | |
| FGTKFRAPPRSAAAS | 86 | Q8WXT5 | |
| FGTKFRAPPRSAAAS | 86 | Q6VB84 | |
| SAHSSRKPFLGAPAA | 441 | O15054 | |
| SSRFGKFIRIHFGPS | 286 | A7E2Y1 | |
| KSPFPARSHFDVSGT | 1121 | Q7Z442 | |
| EQTPGFKSHFLSTPR | 1026 | Q711Q0 | |
| GRLHFPKLRSSSPFS | 156 | Q6ZN03 | |
| PKPVLFSRGSSFRFS | 326 | Q9Y4F1 | |
| RHKPFAANGRSPSRF | 821 | Q4ZHG4 | |
| RKFSSTSSLAAPGRP | 2151 | Q9P0X4 | |
| FTRTFSPSKPAKSLH | 71 | P86791 | |
| FTRTFSPSKPAKSLH | 71 | P86790 | |
| TGHPPSKRARGFSAA | 26 | Q8WXE1 | |
| GFAEHFRTSSPPKIR | 31 | Q9Y6X3 | |
| LPPTPASHRRSSFNF | 1911 | Q01668 | |
| LSPGRSRAFTRKSFH | 316 | Q96NU0 | |
| RTDGFSHSPFGLKPR | 601 | Q5VUJ6 | |
| SHSPFGLKPRSAFSR | 606 | Q5VUJ6 | |
| PFPDSSTHRRLFHKS | 201 | P05121 | |
| PPTKFSGLPRFSHDR | 431 | Q9Y4I5 | |
| FRRAKSSTATHPPGP | 656 | Q14684 | |
| LSSSPPFRLRSAKFS | 16 | Q8WV83 | |
| FSAPRHGSLGFLPRK | 6 | P39023 | |
| FPRKSSFRASTFHPF | 156 | Q8N699 | |
| FGTKFRAPPRSAAAS | 86 | Q5VV16 | |
| FGTKFRAPPRSAAAS | 86 | Q3SYB3 | |
| RSSFAFPPSLAKAGR | 836 | Q14940 | |
| SLHSSFGLGPRFPAS | 276 | O15079 | |
| SRLDFLKASHFSLGP | 16 | Q8NA69 | |
| LRRSHSGPAGSFNKP | 246 | Q9UJM3 | |
| RAHFSRRFLKHSPPG | 1366 | Q8IY92 | |
| KPRSFTLPRDSGFNH | 841 | Q8WXI2 | |
| SFVPHTLFRSQPKSG | 261 | Q9Y6Q2 | |
| RFSASLAPHFNSLPR | 221 | Q96J42 | |
| PGSPFLSRHNSKSSI | 551 | Q9UQD0 | |
| SGFRKALHSDRPPSA | 626 | O00534 | |
| HFSKLTSPRPDAAFA | 16 | P0C7I0 | |
| RPKLHHSLSFSGFPS | 251 | P47974 | |
| FHSPFQSPFRSPLRS | 756 | Q9P2D8 |